xu 62-320 has been researched along with pravastatin sodium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blankley, CJ; Bocan, TM; Chucholowski, AW; Creger, PL; Creswell, MW; Ferguson, E; Newton, RS; O'Brien, P; Picard, JA; Roth, BD | 1 |
| Baret, E; Briolant, S; Fontaine, A; Fusai, T; Henry, M; Mosnier, J; Pradines, B; Rogier, C; Torrentino-Madamet, M | 1 |
2 other study(ies) available for xu 62-320 and pravastatin sodium
| Article | Year |
|---|---|
Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase.
Topics: Animals; Anticholesteremic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Male; Microsomes; Microsomes, Liver; Molecular Structure; Rats; Spleen; Structure-Activity Relationship; Testis | 1991 |
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
Topics: Animals; Antimalarials; Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrroles; Structure-Activity Relationship | 2007 |